Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION (RAD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Rite Aid 4Q Loss Narrows Amid Sales Growth, Tax Benefit

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 07:27pm CEST

--Same-store sales improve for five straight quarters with rollout of loyalty program and renovated stores

--Rite Aid converted 280 stores into new wellness format in the latest quarter

--Loss was greater than analysts expected and new fiscal-year outlook is tempered

(Updates the second paragraph with the latest stock quote and analyst commentary in the eighth through 12th paragraphs.)

 
   By John Kell 
   Of  
 

Rite Aid Corp.'s (>> Rite Aid Corporation) fiscal fourth-quarter loss narrowed as the drug-store company benefited from an extra week of sales and a tax benefit in the latest period.

The chain's loss was greater than analysts expected and its view for the new fiscal year was tempered, though shares were flat at $1.70 in recent trading Thursday as the broader market rallied higher.

The No. 3 U.S. drug-store chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) has posted losses since its 2007 acquisition of the Brooks and Eckerd chains that saddled it with debt just before consumers slashed spending. It has benefited from cutting costs and refinancing billions of dollars in debt, and the company has seen sales growth recently after a long stretch of declines.

Rite Aid's same-store sales have improved for the past five quarters as the company benefits from the rollout of a loyalty program and store renovations under a new format that expands clinical pharmacy services and offers more health and wellness products. Rite Aid converted 280 stores into the new wellness format during the latest quarter, and, while still early in that process, President and Chief Executive John Standley said the effort was helping bolster front-end sales.

Standley told analysts during the company's conference call that enrollment in the Wellness+ loyalty program, which was launched in April 2010, has reached 52 million members and with two years of membership activity the drug-store chain has enough history and data to monitor active members who have used their cards at least twice in the last 26 weeks.

The company's effort to offer more flu immunizations, meanwhile, resulted in the administration of nearly 1.5 million flu shots in the latest fiscal year, more than double the prior year's total. That improvement came amid a mild cold and flu season that hurt the latest quarterly results from CVS and Walgreen.

Standley also noted a marketing campaign helped court customers forced to shift their prescriptions away from Walgreen after that drug-store chain exited from pharmacy-benefit manager Express Scripts Holding Co.'s (ESRX) network following a contract dispute.

Analysts say increasingly contentious contract disputes between payers and providers, as well as reimbursement-rate pressures, would justify consolidation between the top three drug-store chains. Though some speculate Walgreen may look to acquire Rite Aid as a solution to the contract impasse with Express Scripts, others argue a new contract agreement could be reached by this summer.

Raymond James analyst John Ransom said the latest market speculation suggests Walgreen may be more inclined to settle with Express, which earlier this month completed its $29.1 billion acquisition of peer Medco Health Solutions. That would lessen some of the upside thesis to Rite Aid's shares.

Ransom said that even though Rite Aid's new management team "has worked wonders with a really tough hand to play," the company remains heavily leveraged with more than $6 billion in debt and very minimal free cash flow generation.

Imperial Capital analyst Mary Ross Gilbert said her firm has long seen Rite Aid as a longer-term acquisition target, though she notes management continues to improve the business from an operating standpoint. She touted the value of the company's Northeast and West Coast locations and said Rite Aid has kept capital expenditures at a fairly low level.

Ross Gilbert noted Rite Aid's execution of late has kept the business relatively stable and with financial markets in their favor, the company has the ability to refinance maturities as they come due.

For the quarter ended March 3, Rite Aid reported a loss of $161.3 million, or 18 cents a share, from a year-earlier loss of $205.7 million, or 24 cents a share. The latest period included $56.3 million in termination and impairment charges, along with a $24.2 million tax benefit, while the prior year included $154.1 million in charges and a small tax expense.

Analysts polled by Thomson Reuters most recently projected a loss of 14 cents.

Gross margin fell to 24.9% from 26.4%.

Rite Aid recently reported total drug-store sales of $7.12 billion, up 11% from a year earlier, mostly owing to an extra week of sales in the period. Same-store sales improved 3%, the drug-store chain's best showing in five years.

Looking to fiscal 2013, Standley said Rite Aid intends to remodel 500 stores into the wellness format. For the year, the company projected a per-share loss of 13 cents to 31 cents on revenue of $25.4 billion and $25.8 billion. Analysts polled by Thomson Reuters recently expected a loss of 25 cents and revenue of $25.74 billion. Rite Aid expects same-store sales growth of up to 1.5% over the just-completed fiscal year.

-By John Kell, Dow Jones Newswires; 212-416-2480; [email protected]

--Tess Stynes contributed to this article.

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.55% 72.18 Delayed Quote.-2.39%
RITE AID CORPORATION 2.54% 2.02 Delayed Quote.2.54%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
06/23RITE AID : Gunman demands drugs from Rite Aid in Harrison Twp.
AQ
06/21RITE AID CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/21RITE AID : Schedules Special Stockholder Meeting for August 9, 2018 to Vote on t..
BU
06/21RITE AID : Florence Boulevard Rite Aid closes
AQ
06/19HEALTH DIALOG : Joins Clinical, Business and Government Leaders to Discuss Best ..
BU
06/18RITE AID : to Release First Quarter Results on June 27
BU
06/17RITE AID : Car crashes into Rite Aid
AQ
06/15FOLLOW-UP OPEN LETTER TO RITE AID CO : Contact: Chris Komatinsky Individual Sha..
AQ
06/15WAL MART STORES : Columbia County seeks financial transaction card fraud suspect
AQ
06/14Drugstore Chains Adapt New Real Estate Strategies to Compete with Online Sell..
AQ
More news
News from SeekingAlpha
06/23STOCKS TO WATCH : More Trade Tiffs And Stress Tests 
06/19Merger Arbitrage Mondays - June 18, 2018 
06/12Will The Rite Aid - Albertsons Merger Fall Apart? 
06/05Albertsons expected to increase cash portion of Rite Aid bid 
05/18AMAZON GO : Stores Worth Less Than Tech 
Financials ($)
Sales 2019 21 645 M
EBIT 2019 208 M
Net income 2019 -36,9 M
Debt 2019 2 221 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 26,93
EV / Sales 2019 0,20x
EV / Sales 2020 0,19x
Capitalization 2 156 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 2,00 $
Spread / Average Target -0,99%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kermit R. Crawford President & Chief Operating Officer
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION2.54%2 156
RAIA DROGASIL-25.52%5 940
PALTAC CORP21.18%3 668
AIN HOLDINGS INC24.93%2 711
GALENICA AG4.80%2 641
PETMED EXPRESS INC0.59%943